4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-23-000023
CIK 0000894158other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:04 AM ET
Size
5.0 KB
Accession
0001104659-23-000023
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Purchase
Common Stock
2022-12-29$0.44/sh+100,000$43,700→ 110,000 total
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:04 AM ET
- Size
- 5.0 KB